المؤلفون: Nakamura, Yoshiaki, Mizuno, Nobumasa, Sunakawa, Yu, Canon, Jean-Luc, Galsky, Matthew D, Hamilton, Erika, Hayashi, Hidetoshi, Jerusalem, Guy, Kim, Seung Tae, Lee, Keun-Wook, Kankeu Fonkoua, Lionel Aurelien, Monk, Bradley J, Nguyen, Danny, Oh, Do-Youn, Okines, Alicia, O'Malley, David M, Pohlmann, Paula, Reck, Martin, Shin, Sang Joon, Sudo, Kazuki, Takahashi, Shunji, Van Marcke, Cedric, Yu, Evan Y, Groisberg, Roman, Ramos, Jorge, Tan, Sherry, Stinchcombe, Thomas E, Bekaii-Saab, Tanios

المصدر: Journal of Clinical Oncology, 41 (36), 5569 - 5578 (2023-12-20)

مصطلحات موضوعية: Trastuzumab, ERBB2 protein, human, tucatinib, Antibodies, Monoclonal, Humanized, Receptor, ErbB-2, Humans, Trastuzumab/adverse effects, Receptor, ErbB-2/metabolism, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antibodies, Monoclonal, Humanized/adverse effects, Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols, Neoplasms, Oncology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie

Relation: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.00606; urn:issn:0732-183X; urn:issn:1527-7755

URL الوصول: https://orbi.uliege.be/handle/2268/313195

المؤلفون: Jerusalem, Guy, Prat, Aleix, Salgado, Roberto, Reinisch, Mattea, Saura, Cristina, Ruiz-Borrego, Manuel, Nikolinakos, Petros, Ades, Felipe, Filian, Jeiry, Huang, Ning, Mazzei-Abba, Antonella, Tolaney, Sara M

المصدر: Breast, 72, 103580 (2023-12)

مصطلحات موضوعية: Anastrozole, Aromatase inhibitors, Breast neoplasms, Cyclin-dependent kinases, Immune checkpoint inhibitors, Neoadjuvant therapy, Nivolumab, Patient safety, Programmed cell death 1 receptor, ERBB2 protein, human, palbociclib, Receptor, ErbB-2, Receptors, Estrogen, Female, Humans, Neoadjuvant Therapy, Pneumonia, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Breast Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols, Surgery, Oncology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie

Relation: urn:issn:0960-9776; urn:issn:1532-3080

URL الوصول: https://orbi.uliege.be/handle/2268/313197

المؤلفون: Lübbert, Michael, Wijermans, Pierre W, Kicinski, Michal, Chantepie, Sylvain, Van der Velden, Walter J F M, Noppeney, Richard, Griškevičius, Laimonas, Neubauer, Andreas, Crysandt, Martina, Vrhovac, Radovan, Luppi, Mario, Fuhrmann, Stephan, Audisio, Ernesta, Candoni, Anna, Legrand, Olivier, Foà, Robin, Gaidano, Gianluca, van Lammeren-Venema, Danielle, Posthuma, Eduardus F M, Hoogendoorn, Mels, Giraut, Anne, Stevens-Kroef, Marian, Jansen, Joop H, de Graaf, Aniek O, Efficace, Fabio, Ammatuna, Emanuele, Vilque, Jean-Pierre, Wäsch, Ralph, Becker, Heiko, Blijlevens, Nicole, Dührsen, Ulrich, Baron, Frédéric, Suciu, Stefan, Amadori, Sergio, Venditti, Adriano, Huls, Gerwin, EORTC Leukemia Group

المصدر: The Lancet Haematology, 10 (11), e879 - e889 (2023-11)

مصطلحات موضوعية: Decitabine, Cytarabine, Daunorubicin, Humans, Middle Aged, Aged, Decitabine/therapeutic use, Cytarabine/therapeutic use, Daunorubicin/therapeutic use, Transplantation, Homologous, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Leukemia, Myeloid, Acute/drug therapy, Leukemia, Myeloid, Acute/diagnosis, Hematology, Human health sciences, Sciences de la santé humaine, Hématologie

Relation: https://api.elsevier.com/content/article/PII:S2352302623002739?httpAccept=text/xml; urn:issn:2352-3026

URL الوصول: https://orbi.uliege.be/handle/2268/308889

المؤلفون: Fornecker, Luc-Matthieu, Lazarovici, Julien, Aurer, Igor, Casasnovas, René-Olivier, Gac, Anne-Claire, Bonnet, Christophe, Bouabdallah, Krimo, Feugier, Pierre, Specht, Lena, Molina, Lysiane, Touati, Mohamed, Borel, Cécile, Stamatoullas, Aspasia, Nicolas-Virelizier, Emmanuelle, Pascal, Laurent, Lugtenburg, Pieternella, Di Renzo, Nicola, Vander Borght, Thierry, Traverse-Glehen, Alexandra, Dartigues, Peggy, Hutchings, Martin, Versari, Annibale, Meignan, Michel, Federico, Massimo, André, Marc, LYSA-FIL-EORTC Intergroup

المصدر: Journal of Clinical Oncology, 41, 327 - 335 (2023)

مصطلحات موضوعية: Brentuximab Vedotin, Bleomycin, Vinblastine, Doxorubicin, Dacarbazine, Humans, Adolescent, Young Adult, Adult, Middle Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoplasm Staging, Treatment Outcome, Hodgkin Disease/diagnostic imaging, Hodgkin Disease/drug therapy, Hodgkin Disease/pathology, Antineoplastic Combined Chemotherapy Protocols, Hodgkin Disease, Oncology, Cancer Research, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

Relation: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01281; 10.1200/JCO.21.01281; urn:issn:0732-183X; urn:issn:1527-7755

URL الوصول: https://orbi.uliege.be/handle/2268/299780

المؤلفون: Kim, Stefano, Ghiringhelli, Francois, de la Fouchardière, Christelle, Evesque, Ludovic, Smith, Denis, Badet, Nicolas, Samalin, Emmanuelle, Lopez-Trabada Ataz, Daniel, Parzy, Aurelie, Desramé, Jérôme, Baba Hamed, Nabil, Buecher, Bruno, Tougeron, David, Bouché, Olivier, Dahan, Laetitia, Chibaudel, Benoist, El Hajbi, Farid, Mineur, Laurent, Dubreuil, Olivier, Ben Abdelghani, Meher, Pecout, Solange, Bibeau, Frederic, Herfs, Michael, Garcia, Marie-Line, Meurisse, Aurelia, Vernerey, Dewi, Taïeb, Julien, Borg, Christophe

المصدر: The Lancet Oncology, 25 (4), 518 - 528 (2024-04)

مصطلحات موضوعية: Docetaxel, Cisplatin, atezolizumab, Fluorouracil, B7-H1 Antigen, Antibodies, Monoclonal, Humanized, Humans, Female, Middle Aged, Aged, Male, Cisplatin/adverse effects, Fluorouracil/adverse effects, Neoplasm Recurrence, Local/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carcinoma, Squamous Cell, Anus Neoplasms/drug therapy, Oncology, Human health sciences, Sciences de la santé humaine, Oncologie

Relation: https://api.elsevier.com/content/article/PII:S1470204524000810?httpAccept=text/xml; urn:issn:1470-2045; urn:issn:1474-5488

URL الوصول: https://orbi.uliege.be/handle/2268/316241

المؤلفون: Roussel, Murielle, Lauwers-Cances, Valérie, Macro, Margaret, Leleu, Xavier, Royer, Bruno, Hulin, Cyrille, Karlin, Lionel, Perrot, Aurore, Touzeau, Cyrille, Chrétien, Marie-Lorraine, Rigaudeau, Sophie, Dib, Mamoun, Nicolas-Virelizier, Emmanuelle, Escoffre-Barbe, Martine, Belhadj, Karim, Mariette, Clara, Stoppa, Anne-Marie, Araujo, Carla, Doyen, Chantal, Fontan, Jean, Kolb, Brigitte, Garderet, Laurent, Brechignac, Sabine, Malfuson, Jean-Valère, Jaccard, Arnaud, Lenain, Pascal, Borel, Cécile, Hebraud, Benjamin, Benbrahim, Omar, Dorvaux, Véronique, Manier, Salomon, Augeul-Meunier, Karine, Vekemans, Marie-Christiane, Randriamalala, Edouard, Chaoui, Driss, Caers, Jo, Chaleteix, Carine, Benboubker, Lofti, Vincent, Laure, Glaisner, Sylvie, Zunic, Patricia, Slama, Borhane, Eveillard, Jean-Richard, Humbrecht-Kraut, Catherine, Morel, Véronique, Mineur, Philippe, Eisenmann, Jean-Claude, Demarquette, Hélène, Richez, Valentine, Vignon, Marguerite, Caillot, Denis, Facon, Thierry, Moreau, Philippe, Colin, Anne-Laurène, Olivier, Pascale, Wuilleme, Soraya, Avet-Loiseau, Hervé, Corre, Jill, Attal, Michel

المصدر: Blood, 139 (18), 2747-2757 (2022-05-05)

مصطلحات موضوعية: 69G8BD63PP (Bortezomib), Q41OR9510P (Melphalan), Antineoplastic Combined Chemotherapy Protocols/adverse effects, Bortezomib/adverse effects, Humans, Melphalan/adverse effects, Multiple Myeloma/drug therapy/etiology, Transplantation, Autologous, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

Relation: urn:issn:0006-4971; urn:issn:1528-0020

URL الوصول: https://orbi.uliege.be/handle/2268/298028

المؤلفون: Isabella A. J. van Duin, Sjoerd G. Elias, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Willeke A. M. Blokx, Paul J. van Diest, Tim Leiner, Joost J. C. Verhoeff, Rik J. Verheijden, Olivier J. van Not, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, John B. A. G. Haanen, Geke A. P. Hospers, Anna M. Kamphuis, Djura Piersma, Rozemarijn S. van Rijn, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Marion A. M. Stevense‐den Boer, Marye J. Boers‐Sonderen, Ellen Kapiteijn, Karijn P. M. Suijkerbuijk

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Radiology & Nuclear Medicine

المصدر: van Duin, I A J, Elias, S G, van den Eertwegh, A J M, de Groot, J W B, Blokx, W A M, van Diest, P J, Leiner, T, Verhoeff, J J C, Verheijden, R J, van Not, O J, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Haanen, J B A G, Hospers, G A P, Kamphuis, A M, Piersma, D, van Rijn, R S, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Stevense-den Boer, M A M, Boers-Sonderen, M J, Kapiteijn, E & Suijkerbuijk, K P M 2023, ' Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma ', International Journal of Cancer, vol. 152, no. 12, pp. 2493-2502 . https://doi.org/10.1002/ijc.34479
International Journal of Cancer, 152(12), 2493-2502. Wiley
International Journal of Cancer, 152(12), 2493-2502. Wiley-Liss Inc.

مصطلحات موضوعية: Mitogen-Activated Protein Kinase Kinases, Cancer Research, Oncology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Proto-Oncogene Proteins B-raf/genetics, BRAF(/MEK) inhibition, melanoma, SURVIVAL, Humans, immune checkpoint inhibition, immunotherapy, prognosis, Retrospective Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6899fe47da203e306ee373387a5e2107
https://doi.org/10.1002/ijc.34479

المؤلفون: van Zeijl, Michiel C T, van Breeschoten, Jesper, de Wreede, Liesbeth C, Wouters, Michel W J M, Hilarius, Doranne L, Blank, Christian U, Aarts, Maureen J B, van den Berkmortel, Franchette W P J, de Groot, Jan Willem B, Hospers, Geke A P, Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S, Stevense-den Boer, Marion A, van der Veldt, Astrid A M, Vreugdenhil, Gerard, Boers-Sonderen, Marye J, Suijkerbuijk, Karijn P M, Haanen, John B A G, van den Eertwegh, Alfons J M

المساهمون: Internal medicine, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Medical Oncology, Radiology & Nuclear Medicine

المصدر: Journal of Immunotherapy (1997), 46, 197-204
van Zeijl, M C T, van Breeschoten, J, de Wreede, L C, Wouters, M W J M, Hilarius, D L, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Suijkerbuijk, K P M, Haanen, J B A G & van den Eertwegh, A J M 2023, ' Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands ', Journal of Immunotherapy, vol. 46, no. 5, pp. 197-204 . https://doi.org/10.1097/CJI.0000000000000468
Journal of Immunotherapy (1997), 46, 5, pp. 197-204
Journal of Immunotherapy, 46(5), 197-204. Lippincott Williams and Wilkins
Journal of Immunotherapy, 46(5), 197-204. Lippincott Williams & Wilkins

مصطلحات موضوعية: Pharmacology, Cancer Research, Ipilimumab plus nivolumab, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Immunology, real world, Brain Neoplasms/drug therapy, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], population-based, Nivolumab/therapeutic use, POOLED ANALYSIS, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Melanoma/pathology, SURVIVAL, Immunology and Allergy, Humans, METASTATIC MELANOMA, immunotherapy, Ipilimumab/therapeutic use, Netherlands

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5cae1f59afc7919e206ea2bb7ce20f
https://cris.maastrichtuniversity.nl/en/publications/0bab63c2-7c57-472e-b6fd-b12fcc4f0a81

المؤلفون: Gerhardt Attard, Laura Murphy, Noel W Clarke, Ashwin Sachdeva, Craig Jones, Alex Hoyle, William Cross, Robert J Jones, Christopher C Parker, Silke Gillessen, Adrian Cook, Chris Brawley, Clare Gilson, Hannah Rush, Hoda Abdel-Aty, Claire L Amos, Claire Murphy, Simon Chowdhury, Zafar Malik, J Martin Russell, Nazia Parkar, Cheryl Pugh, Carlos Diaz-Montana, Carmel Pezaro, Warren Grant, Helen Saxby, Ian Pedley, Joe M O'Sullivan, Alison Birtle, Joanna Gale, Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzouebi, Omi Parikh, Angus Robinson, Amir H Montazeri, James Wylie, Anjali Zarkar, Richard Cathomas, Michael D Brown, Yatin Jain, David P Dearnaley, Malcolm D Mason, Duncan Gilbert, Ruth E Langley, Robin Millman, David Matheson, Matthew R Sydes, Louise C Brown, Mahesh K B Parmar, Nicholas D James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, Dakshinamoorthy Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, Mohammed Kagzi, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan McLaren, Nishi Gupta, Stergios Boussios, Henry Taylor, John Graham, Carla Perna, Lucinda Melcher, Ami Sabharwal, Uschi Hofmann, Robert Dealey, Neil McPhail, Robert Brierly, Lisa Capaldi, Norma Sidek, Peter Whelan, Peter Robson, Alison Falconer, Sarah Rudman, Sindu Vivekanandan, Vinod Mullessey, Maria Vilarino-Varela, Vincent Khoo, Karen Tipples, Mehran Afshar, Patryk Brulinski, Vijay Sangar, Clive Peedell, Ashraf Azzabi, Peter Hoskin, Viwod Mullassery, Santhanam Sundar, Yakhub Khan, Ruth Conroy, Andrew Protheroe, Judith Carser, Paul Rogers, Kathryn Tarver, Stephanie Gibbs, Mohammad Muneeb Khan, Mohan Hingorani, Simon Crabb, Manal Alameddine, Neeraj Bhalla, Robert Hughes, John Logue, Darren Leaning, Salil Vengalil, Daniel Ford, Georgina Walker, Ahmed Shaheen, Omar Khan, Andrew Chan, Imtiaz Ahmed, Serena Hilman, Ian Sayers, Ashok Nikapota, David Bloomfield, Tim Porter, Joji Joseph, Cyrill Rentsch, Ricardo Pereira Mestre, Enrico Roggero, Jörg Beyer, Markus Borner, Raeto Strebel, Dominik Berthold, Daniel Engeler, Hubert John, Razvan Popescu, Donat Durr

المصدر: STAMPEDE investigators, Attard, G, Murphy, L, Clarke, N W, Sachdeva, A, Jones, C, Hoyle, A, Cross, W, Jones, R J, Parker, C C, Gillessen, S, Cook, A, Brawley, C, Gilson, C, Rush, H, Abdel-Aty, H, Amos, C L, Murphy, C, Chowdhury, S, Malik, Z, Russell, J M, Parkar, N, Pugh, C, Diaz-Montana, C, Pezaro, C, Grant, W, Saxby, H, Pedley, I, O'Sullivan, J M, Birtle, A, Gale, J, Srihari, N, Thomas, C, Tanguay, J, Wagstaff, J, Das, P, Gray, E, Alzouebi, M, Parikh, O, Robinson, A, Montazeri, A H, Wylie, J, Zarkar, A, Cathomas, R, Brown, M D, Jain, Y, Dearnaley, D P, Mason, M D, Gilbert, D, Langley, R E & Millman, R 2023, ' Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol ', Lancet Oncology, vol. 24, no. 5, pp. 443-456 . https://doi.org/10.1016/S1470-2045(23)00148-1
Attard, G, Murphy, L, Clarke, N W, Sachdeva, A, Jones, C, Hoyle, A, Cross, W, Jones, R J, Parker, C C, Gillessen, S, Cook, A, Brawley, C, Gilson, C, Rush, H, Abdel-Aty, H, Amos, C L, Murphy, C, Chowdhury, S, Malik, Z, Russell, J M, Parkar, N, Pugh, C, Diaz-Montana, C, Pezaro, C, Grant, W, Saxby, H, Pedley, I, O'Sullivan, J M, Birtle, A, Gale, J, Srihari, N, Thomas, C, Tanguay, J, Wagstaff, J, Das, P, Gray, E, Alzouebi, M, Parikh, O, Robinson, A, Montazeri, A H, Wylie, J, Zarkar, A, Cathomas, R, Brown, M D, Jain, Y, Dearnaley, D P, Mason, M D, Gilbert, D, Langley, R E & Millman, R 2023, ' Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy : final results from two randomised phase 3 trials of the STAMPEDE platform protocol ', The Lancet. Oncology, vol. 24, no. 5, pp. 443-456 . https://doi.org/10.1016/S1470-2045(23)00148-1

مصطلحات موضوعية: Male, Antineoplastic Combined Chemotherapy Protocols - adverse effects, Docetaxel - therapeutic use, Prednisolone, Abiraterone Acetate, Androgen Antagonists, Prostatic Neoplasms - pathology, Prostatic Neoplasms, Castration-Resistant - drug therapy - pathology, Clinical Trials, Phase III as Topic, Meta-Analysis as Topic, SDG 3 - Good Health and Well-being, Oncology, Androgens, Humans, Randomized Controlled Trials as Topic

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ca84b5aff90123f3e4082a739e1def
https://doi.org/10.1016/s1470-2045(23)00148-1

المؤلفون: Casasnovas, René-Olivier, Bouabdallah, Reda, Brice, Pauline, Lazarovici, Julien, Ghesquieres, Hervé, Stamatoullas, Aspasia, Dupuis, Jehan, Gac, Anne-Claire, Gastinne, Thomas, Joly, Bertrand, Bouabdallah, Krimo, Nicolas-Virelizier, Emmanuelle, Feugier, Pierre, Morschhauser, Franck, Sibon, David, Bonnet, Christophe, Berriolo-Riedinger, Alina, Edeline, Véronique, Parrens, Marie, Damotte, Diane, Coso, Diane, André, Marc, Meignan, Michel, Rossi, Cédric

المصدر: Journal of Clinical Oncology, 40, 1091 - 1101 (2022)

مصطلحات موضوعية: Bleomycin, Procarbazine, Vincristine, Vinblastine, Etoposide, Dacarbazine, Doxorubicin, Cyclophosphamide, Prednisone, Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Follow-Up Studies, Humans, Middle Aged, Neoplasm Staging, Positron-Emission Tomography/methods, Young Adult, Hodgkin Disease/diagnostic imaging, Hodgkin Disease/drug therapy, Neoplasms, Second Primary/pathology, Antineoplastic Combined Chemotherapy Protocols, Hodgkin Disease, Neoplasms, Second Primary, Positron-Emission Tomography, Oncology, Cancer Research, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

Relation: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01777; urn:issn:0732-183X; urn:issn:1527-7755

URL الوصول: https://orbi.uliege.be/handle/2268/299782